Top Articles

Following two recent studies, the Federal Drug Administration (FDA) announced a Permax recall on March 29, 2007. The Permax recall includes both the name brand Perma

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

x (peroglide) and the generic versions of peroglide. Current studies have revealed Permax heart valve disease in around one-fourth of Parkinson's patients who have t

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ken Permax over an extended period of time.

Permax Valvulopathy (valve injuries) first came to the attention of the Federal Drug Administration (FDA) in 2002. Perma

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

was approved by the FDA in 1988. Prior to the Permax recall, the FDA added a black box warning regarding the risk of serious heart valve damage.

Permax side effect

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

including heart valve damage were revealed in the studies published in the New England Journal of Medicine (NEJM). High rates of valve leakage were found in up to 2

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

% of patients prescribed Permax. Dr. Robert Temple, the associate director for medical policy at the Center for Drug Evaluation and Research, stated that Permax (Per

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

oglide) was linked with a fivefold increase in regurgitation of the mitral, atrial, or tricuspid valves compared with the general population. The side effects reveal

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

d in these studies were further evidence of the ongoing problems leading to the Permax recall.

Permax, which is also known as Peroglide, is used in the treatment of

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

Parkinson's patients and also for a condition called Restless Legs Syndrome (RLS). Parkinson's disease is caused by the degeneration of neurons in an area of the bra

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

n involved with movement control that results in a progressive neurological disorder. Restless legs syndrome is also a neurological condition, however it is often mi

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

diagnosed even though it affects around 2.7% of people in the United States. Permax heart valve damage has been reported in both Parkinson's and Restless Legs Syndro

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

me patients around the United States. The Permax recall is expected to affect the future treatment of both Parkinson's and RLS patients.

Permax was released in 1989

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

after being developed by Eli Lilly. Over 500,000 people have taken Permax since 1989 to treat Parkinson's and RLS. Two European studies were conducted in Britain and

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

Italy. In the Italian study, of the 155 people who had taken Permax, 23.4% of them developed Permax heart problems. The British study involved 11,417 people who were

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

taking the drug. Patients in the British study were 37 times more probable to develop Permax heart damage problems. Serious Permax heart valve disease has also been

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

eported by the Mayo Clinic in patients who took the drug and were later diagnosed with heart problems.

The FDA has announced that due to the Permax recall patients

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

with Parkinson's should:
• Contact their healthcare professional to discuss alternate treatment options.
• NOT stop taking Peroglide (Permax) without consu

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ting their healthcare professional, since stopping Permax can be dangerous and several other effective treatments are available.

The FDA has stated that the effect

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

f the Permax recall will not be immediate. There will be a delay which will allow doctors and patients to arrange for appropriate replacement treatment options. Foll

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

wing the Permax recall, the companies that manufacture and distribute peroglide (Permax) are cooperating with the FDA in the removal of the drug from the marketplace

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/130894/toparticles-Permax-Recall.html">Permax Recall</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/130894/toparticles-Permax-Recall.html]Permax Recall[/url]

By developing strong foundation of skills for every employee, an organization creates a greatly empowered workforce focused on achieving the company's goals. An effective grounding in four essential skill sets will remove most, if not all those speed bumps, detours and road blocks that distract organizations, wasting precious time and resources.

In the credit repair world a lot of focus and credibility are given to credit scores. We all know of the FICO score. The so-called official score.

Paying off credit card debt is pretty hard. While many people will tell you to get out of debt by reducing your expenses, it's often easier to eliminate credit card debt by increasing your income. It just takes some effort.

Tags

Links

Top Articles - Permax Recall

Related Articles: